Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temsirolimus vs Temozolomide in MGMT-Unmethylated Glioblastoma
NCT01019434Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Oct 2009
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of temsirolimus in glioblastoma (GBM), sponsored by European Organisation for Research and Treatment of Cancer. Started Oct 2009; status: completed.
02
Drugs
temsirolimus
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT01019434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01019434.